Search by Drug Name or NDC
NDC 44567-0422-24 Magnesium Sulfate 20 g/500mL Details
Magnesium Sulfate 20 g/500mL
Magnesium Sulfate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by WG Critical Care, LLC. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
| NDC | 44567-0422 |
|---|---|
| Product ID | 44567-422_c9c163e2-f368-4481-a24c-f0df8f92732e |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Magnesium Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Magnesium Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | g/500mL |
| Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
| Labeler Name | WG Critical Care, LLC |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207350 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44567-0422-24 (44567042224)
| NDC Package Code | 44567-422-24 |
|---|---|
| Billing NDC | 44567042224 |
| Package | 24 BAG in 1 CARTON (44567-422-24) / 500 mL in 1 BAG |
| Marketing Start Date | 2018-01-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |